Toxoplasmosis landscape: a systematic review and meta-analysis of seroprevalence in healthy and non-healthy individuals in Sudan (1990-2025)
- PMID: 40596963
- PMCID: PMC12220412
- DOI: 10.1186/s12879-025-11265-y
Toxoplasmosis landscape: a systematic review and meta-analysis of seroprevalence in healthy and non-healthy individuals in Sudan (1990-2025)
Abstract
Background: Human toxoplasmosis is a widespread zoonotic infection with significant public health implications, particularly in Sudan, where the disease burden is high. However, the overall prevalence of Toxoplasma gondii infection in the country remains unclear. This systematic review and meta-analysis aimed to estimate the pooled seroprevalence of human toxoplasmosis in Sudan and identify associated risk factors.
Methods: A comprehensive search was conducted in English and Arabic databases for studies published before February 28, 2025, following PRISMA guidelines. The meta-analysis included 60 studies with 10,866 participants from different regions of Sudan.
Results: The pooled seroprevalence of human toxoplasmosis was 36% (95% CI: 31-41%), with significant heterogeneity (I2 = 97.29%, P < 0.0001). Hemodialysis patients exhibited the highest prevalence (56%), followed by women of childbearing age (48%) and HIV patients (42%). Geographically, northern Sudan had the highest prevalence (46%), while western Sudan had the lowest (17%). The latex agglutination test (LAT) was the most frequently used diagnostic method (56.7% of cases). Temporal analysis suggested that the prevalence of toxoplasmosis has slightly declined in recent years, likely due to improved hygiene, sanitation, and increased use of antiparasitic treatments.
Conclusion: Toxoplasmosis remains highly endemic in Sudan, with certain groups-including males, hemodialysis patients, women of childbearing age, HIV patients, and workers exposed to animals-at heightened risk. Targeted public health interventions are necessary to reduce the disease burden among high-risk populations.
Keywords: Human toxoplasmosis; Meta-analysis; Seroprevalence; Sudan; Systematic review.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis.Acta Trop. 2016 Jun;158:160-169. doi: 10.1016/j.actatropica.2016.03.003. Epub 2016 Mar 4. Acta Trop. 2016. PMID: 26952970
-
Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis.Acta Trop. 2014 Sep;137:185-94. doi: 10.1016/j.actatropica.2014.05.015. Epub 2014 Jun 2. Acta Trop. 2014. PMID: 24887263
-
A systematic review and meta-analysis of the seroprevalence of Toxoplasma gondii in cats in mainland China.Parasit Vectors. 2017 Jan 13;10(1):27. doi: 10.1186/s13071-017-1970-6. Parasit Vectors. 2017. PMID: 28086987 Free PMC article.
-
A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population.Parasit Vectors. 2012 Nov 26;5:271. doi: 10.1186/1756-3305-5-271. Parasit Vectors. 2012. PMID: 23181616 Free PMC article.
-
Seroprevalence of Toxoplasma gondii in Equids: A Global Systematic Review and Meta-analysis.Acta Parasitol. 2025 Aug 7;70(4):167. doi: 10.1007/s11686-025-01108-w. Acta Parasitol. 2025. PMID: 40773076 Review.
References
-
- Wang ZD, Wang SC, Liu HH, Ma HY, Li ZY, Wei F, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4(4):e177–88. - PubMed
-
- Anvari D, Sharif M, Sarvi S, Aghayan SA, Gholami S, Pagheh AS, et al. Seroprevalence of Toxoplasma gondii infection in cancer patients: A systematic review and meta-analysis. Microb Pathog. 2019;129:30–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials